The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma.
about
Comparative transcriptomic analysis reveals the oncogenic fusion protein PAX3-FOXO1 globally alters mRNA and miRNA to enhance myoblast invasion.Sirolimus and metformin synergistically inhibit hepatocellular carcinoma cell proliferation and improve long-term survival in patients with HCC related to hepatitis B virus induced cirrhosis after liver transplantation.Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study.Insulin-IGF signaling affects cell transformation in the BALB/c 3T3 cell model.
P2860
The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The dual targeting of insulin ...... y in hepatocellular carcinoma.
@en
type
label
The dual targeting of insulin ...... y in hepatocellular carcinoma.
@en
prefLabel
The dual targeting of insulin ...... y in hepatocellular carcinoma.
@en
P2093
P2860
P50
P356
P1433
P1476
The dual targeting of insulin ...... cy in hepatocellular carcinoma
@en
P2093
Annamaria Colao
Claudia Pivonello
Donatella Paola Provvisiero
Gaia Cuomo
Leo J Hofland
Maria Cristina De Martino
Mariarosaria Negri
Renata Simona Auriemma
Rosario Pivonello
P2860
P304
P356
10.18632/ONCOTARGET.6836
P407
P577
2016-03-01T00:00:00Z